Trilotab 60 mg chewable tablets for dogs
Trilotab 60 mg chewable tablets for dogs
Authorised
- Trilostane
Product identification
Medicine name:
Trilotab 60 mg chewable tablets for dogs
Trilotab 60 mg Kautabletten für Hunde
Active substance:
- Trilostane
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Trilostane60.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Chewable tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH02CA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Available in:
-
Germany
Package description:
- Aluminium-PVC/Aluminium/oPA blisters, containing 10 tablets. Cardboard box of 10 blisters of 10 tablets
- Aluminium-PVC/Aluminium/oPA blisters, containing 10 tablets. Cardboard box of 3 blister of 10 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
- CP-Pharma Handelsgesellschaft mbH
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- V7008597.00.00
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0373/003
Concerned member states:
-
Austria
-
Belgium
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Poland
-
Portugal
-
Slovakia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
Generic of:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
